Feasibility of Patient-Controlled Sleep with Dexmedetomidine in Treating Chronic Intractable Insomnia

References

• Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97–111. doi:10.1053/smrv.2002.0186
   PubMed Web of Science ®Google Scholar
• Fan TT, Chen WH, Shi L, et al. Objective sleep duration is associated with cognitive deficits in primary insomnia: BDNF may play a role. Sleep. 2019;42.
   Web of Science ®Google Scholar
• Equihua-Benitez AC, Guzman-Vasquez K, Drucker-Colin R. Understanding sleep-wake mechanisms and drug discovery. Expert Opin Drug Discov. 2017;12(7):643–657. doi:10.1080/17460441.2017.1329818
   PubMed Web of Science ®Google Scholar
• Brietzke E, Vazquez GH, Kang MJY, Soares CN. Pharmacological treatment for insomnia in patients with major depressive disorder. Expert Opin Pharmacother. 2019;20:1341–1349.
   PubMed Web of Science ®Google Scholar
• Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf. 2003;26(4):261–282. doi:10.2165/00002018-200326040-00004
   PubMed Web of Science ®Google Scholar
• Manconi M, Ferri R, Miano S, et al. Sleep architecture in insomniacs with severe benzodiazepine abuse. Clin Neurophysiol. 2017;128(6):875–881. doi:10.1016/j.clinph.2017.03.009
   Web of Science ®Google Scholar
• Lehmann KA. New developments in patient-controlled postoperative analgesia. Ann Med. 1995;27:271–282.
   PubMed Web of Science ®Google Scholar
• Cook LB, Lockwood GG, Moore CM. True patient-controlled sedation. Anaesthesia. 2007;48(12):1039–1044. doi:10.1111/j.1365-2044.1993.tb07521.x
   Google Scholar
• Rudkin GE, Osborne GA, Finn BP, Jarvis DA, Vickers D. Intra-operative patient-controlled sedation. Comparison of patient-controlled propofol with patient-controlled midazolam. Anaesthesia. 1992;47(5):376–381. doi:10.1111/j.1365-2044.1992.tb02216.x
   PubMed Web of Science ®Google Scholar
• Chlan LL. Engaging critically ill patients in symptom management: thinking outside the box! Am J Crit Care. 2016;25(4):293–300. doi:10.4037/ajcc2016932
   Web of Science ®Google Scholar
• Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009;43(12):2064–2074. doi:10.1345/aph.1M310
   PubMed Web of Science ®Google Scholar
• Wu XH, Cui F, Zhang C. Low-dose dexmedetomidine improves sleep quality pattern in elderly patients after noncardiac surgery in the intensive care unit: a pilot randomized controlled trial. Anesthesiology. 2016;125:979–991. doi:10.1097/ALN.0000000000001325
   PubMed Web of Science ®Google Scholar
• Huupponen E, Maksimow A, Lapinlampi P. Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiol Scand. 2008;52(2):289–294. doi:10.1111/j.1399-6576.2007.01537.x
   PubMed Web of Science ®Google Scholar
• Weerink MAS, Struys MMRF, Hannivoort LN. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893–913. doi:10.1007/s40262-017-0507-7
   PubMed Web of Science ®Google Scholar
• World Medical Association. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Riemann D, Spiegelhalder K, Feige B. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev. 2010;14(1):19–31. doi:10.1016/j.smrv.2009.04.002
   PubMed Web of Science ®Google Scholar
• Chernik DA, Gillings D, Laine H. Validity and reliability of the observer’s assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244–251.
   PubMed Web of Science ®Google Scholar
• Koelsch S, Heinke W, Sammler D, Olthoff D. Auditory processing during deep propofol sedation and recovery from unconsciousness. Clin Neurophysiol. 2006;117(8):1746–1759. doi:10.1016/j.clinph.2006.05.009
   Web of Science ®Google Scholar
• Tsai PS, Wang SY, Wang MY. Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res. 2005;14(8):1943–1952. doi:10.1007/s11136-005-4346-x
   PubMed Web of Science ®Google Scholar
• Guldenmund P, Vanhaudenhuyse A, Sanders RD. Brain functional connectivity differentiates dexmedetomidine from propofol and natural sleep. Br J Anaesth. 2017;119(4):674–684. doi:10.1093/bja/aex257
   PubMed Web of Science ®Google Scholar
• Akeju O, Hobbs LE, Gao L, et al. Dexmedetomidine promotes biomimetic non-rapid eye movement stage 3 sleep in humans: a pilot study. Clin Neurophysiol. 2018;129(1):69–78. doi:10.1016/j.clinph.2017.10.005
   PubMed Web of Science ®Google Scholar
• Alkadhi K, Zagaar M, Alhaider I. Neurobiological consequences of sleep deprivation. Curr Neuropharmacol. 2013;11(3):231–249. doi:10.2174/1570159X11311030001
   Web of Science ®Google Scholar
• Shokri-Kojori E, Wang GJ, Wiers CE. β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A. 2018;115(17):4483–4488. doi:10.1073/pnas.1721694115
   PubMed Web of Science ®Google Scholar
• Lv J, Wei Y, Chen Y. Dexmedetomidine attenuates propofol-induce neuroapoptosis partly via the activation of the PI3k/Akt/GSK3β pathway in the hippocampus of neonatal rats. Environ Toxicol Pharmacol. 2017;52:121–128. doi:10.1016/j.etap.2017.03.017
   PubMed Web of Science ®Google Scholar
• Ma D, Hossain M, Rajakumaraswamy N. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol. 2004;502(1–2):87–97. doi:10.1016/j.ejphar.2004.08.044
   PubMed Web of Science ®Google Scholar
• Sanders RD, Xu J, Shu Y. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology. 2009;110(5):1077–1085. doi:10.1097/ALN.0b013e31819daedd
   PubMed Web of Science ®Google Scholar
• Xie L, Kang H, Xu Q. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373–377. doi:10.1126/science.1241224
   PubMed Web of Science ®Google Scholar
• Fuxe K, Agnati LF, Marcoli M, Borroto-Escuela DO. Volume transmission in central dopamine and noradrenaline neurons and its astroglial targets. Neurochem Res. 2015;40(12):2600–2614. doi:10.1007/s11064-015-1574-5
   Web of Science ®Google Scholar
• Nguyen V, Tiemann D, Park E, Salehi A. Alpha-2 agonists. Anesthesiol Clin. 2017;35(2):233–245. doi:10.1016/j.anclin.2017.01.009
   PubMedGoogle Scholar
• Hu J, Lv BF, Guo WJ, et al. Effects of dexmedetomidine on the pharmacokinetics of parecoxib and its metabolite valdecoxib in beagles by UPLC-MS/MS. Biomed Res Int. 2020;1563874.
   Web of Science ®Google Scholar
• Stiehl SR, Squires JE, Bucuvalas JC, et al. Tacrolimus interaction with dexmedetomidine–a case report. Pediatr Transplant. 2016;20(1):155–157. doi:10.1111/petr.12618
   Web of Science ®Google Scholar
• Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technol Assess. 2004;8(8):1–68. doi:10.3310/hta8080
   Web of Science ®Google Scholar
• Jansen PR, Watanabe K, Stringer S. Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways. Nat Genet. 2019;51(3):394–403. doi:10.1038/s41588-018-0333-3
   PubMed Web of Science ®Google Scholar
• Lane JM, Jones SE, Dashti HS. Biological and clinical insights from genetics of insomnia symptoms. Nat Genet. 2019;51(3):387–393. doi:10.1038/s41588-019-0361-7
   PubMed Web of Science ®Google Scholar